Till de Bortoli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Till de Bortoli has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Albrecht Stenzinger
German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Sites Berlin and Heidelberg, Germany; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany
1 shared publication- Damian Tobias Rieke
Comprehensive Cancer Center, Charité–Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
1 shared publication Frederick Klauschen
German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Sites Berlin and Heidelberg, Germany; Institute of Pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117 Berlin, Germany
1 shared publicationIngeborg Tinhofer
German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Sites Berlin and Heidelberg, Germany; Department of Radiooncology and Radiotherapy, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117 Berlin, Germany
1 shared publication- Ivan Jelas
Charité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, Berlin, Germany; Department of Hematology, Oncology and Cancer Immunology, Campus Charité Mitte, Charité - Universitätsmedizin Berlin, Berlin, Germany
1 shared publication - Manuela Benary
Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Core Unit Bioinformatics, Berlin, Germany
1 shared publication
Latest Publications
- 4 August 2023
- Published by Elsevier in European Journal of Cancer
- Vol. 190, 112925
Tumour mutational burden and survival with molecularly matched therapy
- 4 August 2023
- Published by Elsevier in European Journal of Cancer
- Vol. 190, 112925
Tumour mutational burden and survival with molecularly matched therapy